The Mullally Laboratory is based at Brigham and Women’s Hospital, with links to Dana-Farber Cancer Institute, Broad Institute and Harvard Stem Cell Institute. The primary focus of the laboratory is the biology and treatment of myeloid malignancies, in particular, myeloproliferative neoplasms.